title: Comparison of in vitro assays of cellular toxicity in the human hepatic cell line HepG2.
abstract: Cytotoxicity testing allows determining whether a compound or extract contains significant quantities of biologically harmful chemicals. Cytotoxicity test methods are useful for screening because they serve to separate toxic from nontoxic materials, providing predictive evidence of compound safety. However, a wide range of assays measuring different aspects of cell death is available in the market, but it is difficult to determine which one(s) to use when evaluating a selection of compounds. The objective of this study was to compare different commercially available in vitro assays for cytotoxicity in HepG2 cells according to its sensitivity, reproducibility, simplicity, cost, and speed. The assays evaluated included Alamar Blue for the measurement of mitochondrial activity, ATPlite and ViaLight for the determination of cellular adenosine triphosphate (ATP), ToxiLight as an indicator of cellular necrosis, and Caspase-3 Fluorometric Assay, Apo-ONE Caspase-3/7 Homogeneous Assay, and Caspase-Glo for the determination of caspase-3/7 activity. All assays were performed using 4 compounds of previously reported cytotoxic activity: DMSO, butyric acid, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), and camptothecine. Overall, it was concluded that the best way to evaluate the potential cytotoxicity of a compound is to employ a battery of assays that focus on different aspects of cell death. In this case, the focus has been on ATP levels, cell necrosis, and capsase-3/7 activation. Many other kits are commercially available in the market for these and other aspects of necrosis and/or apoptosis. However, the use of ViaLight Plus, ToxiLight, and Caspase-3 Fluorometric Assay resulted in the most useful combination when working with HepG2 cells.
authors.affiliation: Unilever R&D Vlaardingen, Unilever Health Institute, Vlaardingen, the Netherlands. silvia.miret-catalan@unilever.com
authors.forename: Silvia
authors.initials: S
authors.lastname: Miret
authors.forename: Els M
authors.initials: EM
authors.lastname: De Groene
authors.forename: Werner
authors.initials: W
authors.lastname: Klaffke
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000826:Animal Testing Alternatives; D000818:Animals; D053148:Caspase 3; D053179:Caspase 7; D020169:Caspases / Q000378:metabolism; D002460:Cell Line; D022781:Hepatocytes / Q000187:drug effects*; D006801:Humans; D010078:Oxazines / Q000737:chemistry; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D018675:Toxicity Tests / Q000191:economics / Q000379:methods*; D014966:Xanthenes / Q000737:chemistry
chemical_list: D010078:Oxazines; D014966:Xanthenes; C005843:resazurin; D000255:Adenosine Triphosphate; C505407:CASP3 protein, human; C505520:CASP7 protein, human; D053148:Caspase 3; D053179:Caspase 7; D020169:Caspases